Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates
- PMID: 19748398
- DOI: 10.1016/S0140-6736(09)61204-6
Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates
Abstract
Background: Streptococcus pneumoniae is a leading cause of bacterial pneumonia, meningitis, and sepsis in children worldwide. However, many countries lack national estimates of disease burden. Effective interventions are available, including pneumococcal conjugate vaccine and case management. To support local and global policy decisions on pneumococcal disease prevention and treatment, we estimated country-specific incidence of serious cases and deaths in children younger than 5 years.
Methods: We measured the burden of pneumococcal pneumonia by applying the proportion of pneumonia cases caused by S pneumoniae derived from efficacy estimates from vaccine trials to WHO country-specific estimates of all-cause pneumonia cases and deaths. We also estimated burden of meningitis and non-pneumonia, non-meningitis invasive disease using disease incidence and case-fatality data from a systematic literature review. When high-quality data were available from a country, these were used for national estimates. Otherwise, estimates were based on data from neighbouring countries with similar child mortality. Estimates were adjusted for HIV prevalence and access to care and, when applicable, use of vaccine against Haemophilus influenzae type b.
Findings: In 2000, about 14.5 million episodes of serious pneumococcal disease (uncertainty range 11.1-18.0 million) were estimated to occur. Pneumococcal disease caused about 826,000 deaths (582,000-926,000) in children aged 1-59 months, of which 91,000 (63,000-102,000) were in HIV-positive and 735,000 (519,000-825,000) in HIV-negative children. Of the deaths in HIV-negative children, over 61% (449,000 [316,000-501,000]) occurred in ten African and Asian countries.
Interpretation: S pneumoniae causes around 11% (8-12%) of all deaths in children aged 1-59 months (excluding pneumococcal deaths in HIV-positive children). Achievement of the UN Millennium Development Goal 4 for child mortality reduction can be accelerated by prevention and treatment of pneumococcal disease, especially in regions of the world with the greatest burden.
Funding: GAVI Alliance and the Vaccine Fund.
Comment in
-
The deadly toll of S pneumoniae and H influenzae type b.Lancet. 2009 Sep 12;374(9693):854-6. doi: 10.1016/S0140-6736(09)61608-1. Lancet. 2009. PMID: 19748384 No abstract available.
-
Scarcity of pneumococcal vaccine where it is needed most.Lancet. 2009 Nov 28;374(9704):1820. doi: 10.1016/S0140-6736(09)62058-4. Lancet. 2009. PMID: 19944862 No abstract available.
Similar articles
-
The Global Landscape of Pediatric Bacterial Meningitis Data Reported to the World Health Organization-Coordinated Invasive Bacterial Vaccine-Preventable Disease Surveillance Network, 2014-2019.J Infect Dis. 2021 Sep 1;224(12 Suppl 2):S161-S173. doi: 10.1093/infdis/jiab217. J Infect Dis. 2021. PMID: 34469555 Free PMC article.
-
National, regional, and state-level burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in India: modelled estimates for 2000-15.Lancet Glob Health. 2019 Jun;7(6):e735-e747. doi: 10.1016/S2214-109X(19)30081-6. Lancet Glob Health. 2019. PMID: 31097277 Free PMC article.
-
Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15.Lancet Glob Health. 2018 Jul;6(7):e744-e757. doi: 10.1016/S2214-109X(18)30247-X. Lancet Glob Health. 2018. PMID: 29903376 Free PMC article.
-
Paediatric pneumococcal disease in Central Europe.Eur J Clin Microbiol Infect Dis. 2011 Nov;30(11):1311-20. doi: 10.1007/s10096-011-1241-y. Epub 2011 Jun 11. Eur J Clin Microbiol Infect Dis. 2011. PMID: 21667219 Review.
-
Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates.Lancet. 2009 Sep 12;374(9693):903-11. doi: 10.1016/S0140-6736(09)61203-4. Lancet. 2009. PMID: 19748399 Review.
Cited by
-
Nasopharyngeal carriage of Streptococcus pneumoniae in Latin America and the Caribbean: A systematic review and meta-analysis.PLoS One. 2024 May 20;19(5):e0297767. doi: 10.1371/journal.pone.0297767. eCollection 2024. PLoS One. 2024. PMID: 38768099 Free PMC article.
-
Lipidation of pneumococcal proteins enables activation of human antigen-presenting cells and initiation of an adaptive immune response.Front Immunol. 2024 Apr 22;15:1392316. doi: 10.3389/fimmu.2024.1392316. eCollection 2024. Front Immunol. 2024. PMID: 38711516 Free PMC article.
-
Invasive pneumococcal diseases in Chinese children: a multicentre hospital-based active surveillance from 2019 to 2021.Emerg Microbes Infect. 2024 Dec;13(1):2332670. doi: 10.1080/22221751.2024.2332670. Epub 2024 Apr 25. Emerg Microbes Infect. 2024. PMID: 38646911 Free PMC article.
-
Phylogenetic inference of pneumococcal transmission from cross-sectional data, a pilot study.Wellcome Open Res. 2023 Oct 6;8:427. doi: 10.12688/wellcomeopenres.19219.1. eCollection 2023. Wellcome Open Res. 2023. PMID: 38638914 Free PMC article.
-
A multicenter clinical epidemiology of pediatric pneumococcal meningitis in China: results from the Chinese Pediatric Bacterial Meningitis Surveillance (CPBMS) 2019-2020.Front Cell Infect Microbiol. 2024 Mar 15;14:1353433. doi: 10.3389/fcimb.2024.1353433. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38558854 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical